{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:01:22Z","timestamp":1790355682296,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01577","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T15:23:52Z","timestamp":1562253832000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses"],"prefix":"10.3389","volume":"10","author":[{"given":"Roshan","family":"Pais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Omosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph U.","family":"Igietseme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Fujihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis O.","family":"Eko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"B1","first-page":"3","article-title":"Epidemiology of human chlamydial infections","volume-title":"Chlamydial Infections.","author":"Schachter","year":"1998"},{"key":"B2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/9781555818203.ch8","article-title":"Human immunity to Chlamydiae","volume-title":"Chlamydia: Intracellular Biology, Pathogenesis, and Immunity.","author":"Brunham","year":"1999"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/S0264-410X(02)00677-1","article-title":"Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis","volume":"21","author":"Eko","year":"2003","journal-title":"Vaccine."},{"key":"B4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.emc.2019.01.001","article-title":"Sexually transmitted diseases in the emergency department","volume":"37","author":"Pfennig","year":"2019","journal-title":"Emerg Med Clin N Am."},{"key":"B5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S1357-4310(98)01232-5","article-title":"Vaccines against Chlamydia: approaches and progress","volume":"4","author":"Stagg","year":"1998","journal-title":"Mol Med Today."},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00063030-200216010-00003","article-title":"Chlamydia vaccines: strategies and status","volume":"16","author":"Igietseme","year":"2002","journal-title":"Bio Drugs."},{"key":"B7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1586\/14760584.2.1.129","article-title":"Contemporary approaches to designing and evaluating vaccines against Chlamydia","volume":"2","author":"Igietseme","year":"2003","journal-title":"Expert Rev Vaccines."},{"key":"B8","first-page":"218","article-title":"Chlamydia trachomatis antigens: role in immunity and pathogenesis","volume":"3","author":"Brunham","year":"1994","journal-title":"Infect Agents Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/jrf.0.0950031","article-title":"Genetic susceptibility to chlamydial salpingitis and subsequent infertility in mice","volume":"95","author":"Tuffrey","year":"1992","journal-title":"J Reprod Fertil."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1099\/00221287-139-12-2965","article-title":"Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis","volume":"139","author":"Batteiger","year":"1993","journal-title":"J Gen Microbiol."},{"key":"B11","first-page":"8","article-title":"A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo","volume":"85","author":"Knight","year":"1995","journal-title":"Immunology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1126\/science.282.5389.754","article-title":"Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis","volume":"282","author":"Stephens","year":"1998","journal-title":"Science."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1073\/pnas.0508983103","article-title":"From the cover: Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen","volume":"103","author":"Crane","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1086\/315631","article-title":"Chlamydial genomics and vaccine antigen discovery","volume":"181","author":"Stephens","year":"2000","journal-title":"J Infect Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/S0264-410X(02)00680-1","article-title":"Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge","volume":"21","author":"Pal","year":"2003","journal-title":"Vaccine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.4049\/jimmunol.173.5.3375","article-title":"A novel recombinant multisubunit vaccine against Chlamydia","volume":"173","author":"Eko","year":"2004","journal-title":"J Immunol."},{"key":"B17","first-page":"1472","article-title":"Induction of immune memory by a multisubunit chlamydial vaccine","volume-title":"Vaccine.","author":"Eko","year":"2011"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1016\/j.vaccine.2011.03.027","article-title":"Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate","volume":"29","author":"Eko","year":"2011","journal-title":"Vaccine."},{"key":"B19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1046\/j.1365-2958.2000.02167.x","article-title":"Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target","volume":"38","author":"Kubo","year":"2000","journal-title":"Mol Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1073\/pnas.0508983103","article-title":"From the cover: Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen","volume":"103","author":"Crane","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0178537","DOI":"10.1371\/journal.pone.0178537","article-title":"Rectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice","volume":"12","author":"Pais","year":"2017","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cellimm.2006.10.002","article-title":"The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells","volume":"242","author":"Murphey","year":"2006","journal-title":"Cell Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e5409","DOI":"10.1371\/journal.pone.0005409","article-title":"A vault nanoparticle vaccine induces protective mucosal immunity","volume":"4","author":"Champion","year":"2009","journal-title":"PLoS ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1016\/j.vaccine.2009.08.001","article-title":"Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections","volume":"27","author":"Hickey","year":"2009","journal-title":"Vaccine."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1128\/IAI.06339-11","article-title":"PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice","volume":"80","author":"Johnson","year":"2012","journal-title":"Infect Immun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1128\/IAI.06338-11","article-title":"Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice","volume":"80","author":"Yu","year":"2012","journal-title":"Infect Immun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1084\/jem.20030323","article-title":"Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo","volume":"198","author":"Karsunky","year":"2003","journal-title":"J Exp Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/sj.cgt.7701081","article-title":"Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2\/neu DNA vaccine","volume":"14","author":"Yo","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.vaccine.2010.01.043","article-title":"A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx","volume":"28","author":"Kodama","year":"2010","journal-title":"Vaccine."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.4049\/jimmunol.1002837","article-title":"A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice","volume":"186","author":"Fukuyama","year":"2011","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.vaccine.2011.10.093","article-title":"A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging","volume":"30","author":"Asanuma","year":"2012","journal-title":"Vaccine."},{"key":"B32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0168-1656(00)00315-1","article-title":"Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili","volume":"83","author":"Eko","year":"2000","journal-title":"J Biotechnol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/0264-410X(95)00017-U","article-title":"Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against genital tract infection","volume":"13","author":"Su","year":"1995","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1586\/14760584.3.1.23","article-title":"Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens","volume":"3","author":"Igietseme","year":"2004","journal-title":"Expert Rev Vaccines."},{"key":"B35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0167-5699(99)01468-1","article-title":"Regional specialization in the mucosal immune system: primed cells do not always home along the same track","volume":"20","author":"Brandtzaeg","year":"1999","journal-title":"Immunol Today."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/S0264-410X(02)00155-X","article-title":"A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants","volume":"20","author":"Fujihashi","year":"2002","journal-title":"Vaccine."},{"key":"B37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1574-695X.2008.00493.x","article-title":"A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin","volume":"55","author":"Ekong","year":"2009","journal-title":"FEMS Immunol Med Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0896-8411(03)00044-1","article-title":"The complex role of interleukin-10 in autoimmunity","volume":"20","author":"Groux","year":"2003","journal-title":"J Autoimmun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytok Growth Factor Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"E823","DOI":"10.1073\/pnas.1107913108","article-title":"B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice","volume":"108","author":"Scapini","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1600-0897.2005.00267.x","article-title":"Immunologic uniqueness of the genital tract: challenge for vaccine development","volume":"53","author":"Mestecky","year":"2005","journal-title":"Am J Reprod Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jri.2009.07.013","article-title":"The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women","volume":"83","author":"Agrawal","year":"2009","journal-title":"J R Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1086\/377134","article-title":"Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens","volume":"188","author":"Moore","year":"2003","journal-title":"J Infect Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1128\/IAI.01360-10","article-title":"The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia","volume":"79","author":"Kataoka","year":"2011","journal-title":"Infect Immun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/sj.gt.3301783","article-title":"Generation of potent and specific cellular immune responses via in vivo stimulation of dendritic cells by pNGVL3-hFLex plasmid DNA and immunogenic peptides","volume":"17","author":"Fong","year":"2002","journal-title":"Gene Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.4049\/jimmunol.169.7.3837","article-title":"DNA-encoded fetal liver tyrosine Kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbred animals","volume":"169","author":"Mwangi","year":"2002","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1128\/IAI.01280-06","article-title":"Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production","volume":"75","author":"Murthy","year":"2007","journal-title":"Infect Immun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.4049\/jimmunol.180.5.3375","article-title":"Antigen-specific CD4+ T cells produce sufficient IFN-{gamma} to mediate robust protective immunity against genital Chlamydia muridarum infection","volume":"180","author":"Li","year":"2008","journal-title":"J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.4049\/jimmunol.182.3.1602","article-title":"Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models","volume":"182","author":"Yu","year":"2009","journal-title":"J Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1128\/IAI.01374-09","article-title":"Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA\/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-{gamma})\/tumor necrosis factor alpha and IFN-{gamma}\/interleukin-17 double-positive CD4+ T cells","volume":"78","author":"Yu","year":"2010","journal-title":"Infect Immun."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01577\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T17:38:12Z","timestamp":1569260292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01577\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2019.01577"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01577","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"article-number":"1577"}}